glp-1 cancer risk of pancreatic associated with receptor agonist therapy GLP-1 drugs may reduce cancer

Yes, potential side effects include fatigue, which some patients may experience during treatment

Most health insurance carriers will cover tirzepatide for weight loss for people who are obese or overweight with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol

There's also a larger question hanging over the Medicare breakthrough: Unless the Trump administration extends or replaces the demonstration program, obesity drug coverage is scheduled to expire at the end of 2027

Binge eating disorder is characterized by recurrent episodes of binge eating (where someone eats a large amount of food in a short period of time while feeling out of control), and it can do significant harm to a persons mental and physical health, increasing the risk of diabetes, cardiovascular disease, nutritional deficiencies, and sleep disorders

Wegovy lawsuits allege that manufacturer Novo Nordisk failed to warn consumers of all risks, negligently misrepresented the product and engaged in harmful marketing practices

(Cocaine- and Amphetamine-Regulated Transcript) Is a Novel Intraovarian Mediator of Obesity-Related Infertility in Females